Schott Phar­ma plans Frank­furt Stock Ex­change list­ing by end of year to boost of­fer­ing to in­jectable drug com­pa­nies

Drug con­tain­er sup­pli­er Schott Phar­ma re­vealed Wednes­day it is mak­ing plans to be pub­licly list­ed on the Frank­furt Stock Ex­change by the end of the year in a bid to fund the com­pa­ny’s fur­ther ex­pan­sion in­to the in­jectable drug mar­ket.

The cap­i­tal raised will in­crease the Mainz, Ger­many-head­quar­tered com­pa­ny’s pro­duc­tion ca­pac­i­ty at its Ger­man and US fa­cil­i­ties and fund a new man­u­fac­tur­ing site in Hun­gary. The IPO will al­so sup­port the com­pa­ny’s goal to be­come cli­mate-neu­tral by 2030.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.